Our website uses cookies to enable essential features and improve your browsing experience. Additionally, cookies enhance overall website functionality and user experience. By choosing I Accept, you agree to our use of non-essential cookies and other tracking technologies.

You have the ability to manage your settings or withdraw your consent at any time. We are committed to maintaining the privacy and security of your personal information. For detailed information on how we use cookies, including how to manage your privacy and preferences, please visit our cookie policy .
Developmentaid logo
Register
Print
Print
Gates Foundation

Global: To enhance protein expression via novel mRNA designs to enhance vaccine and therapeutic availability for those in the developing world

Last update: 2 days ago Last update: Mar 25, 2026

Details

Locations:Poland
Start Date:Oct, 2022
End Date:Dec, 2023
Contract value: USD 813,578
Sectors:Health
 Health
Categories:Grants
Funding Agencies:
Gates Foundation
Date posted:Mar 25, 2026

Associated funding

Associated experts

Description

Purpose: To enhance protein expression via novel mRNA designs to enhance vaccine and therapeutic availability for those in the developing world
Division: Global Health
Region served: GLOBAL
Grant topic: Create Novel Technology Platform Capabilities
Duration (months): 14
Grantee location: Warszawa, Poland

Want to unlock full information?
Member-only information. Become a member to access projects awards, find the right consortia partners, subcontractors and more.
Learn more about our membership benefits
Print